Skip to main content

Table 3 Area under the ROC curve comparisons

From: The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya

Comparison Groups

PCS AUC

MCS AUC

SF6D AUC

CD4 < 200 vs CD4 ≥ 200

0.61

0.61

0.61

Viral Load ≤55,000 vs >55,000

0.56

0.54

0.57

WHO stage 1 vs stage 2

0.55

0.58

0.55

WHO stage 1 vs stage 3

0.67

0.67

0.64

WHO stage 1 vs stage 4

0.72

0.71

0.68